HARMONY BIOSCIENCES HOLDINGS
HRMY · NASDAQ
更新於 2026-10-15 09:31:54
$37.51+1.29%
- 今日最高
- $38.31
- 今日最低
- $36.92
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
...
K線圖趨勢，實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $37.16
- 昨天收盤價
- $37.51
- 成交量
- 972.24K
- 市值
- $2.18B
- 市盈率（P/E）
- 12.00X
- 每股收益（EPS）
- $3.09
昨天價格區間
$36.92$38.31
52週價格區間
$25.52$43.49
公司概況
- 板塊
- 醫療保健
- 行業
- 製藥
- 子行業
- 生物科技
- 總部
- 美國賓夕法尼亞州普利茅斯會議西日耳曼敦派克 630 號，郵編 19462
- 國家
- 美國
- 上市日期
- 2020-08-19
- 財年截止
- 十二月
- 流通股數
- 57.89M
- CIK
- 0001802665
Harmony Biosciences Holdings, Inc. 是一家處於商業化階段的製藥公司，致力為罕見神經系統疾病患者開發及推廣療法。公司總部設於賓夕法尼亞州普利茅斯會議。
財務指標
營業收入
2026-06-30
$261.28M
2026-03-31
$215.38M
2025-12-31
$243.77M
2025-09-30
$239.45M
營業支出
2026-06-30
$108.76M
2026-03-31
$133.58M
2025-12-31
$136.67M
2025-09-30
$114.31M
淨利潤
2026-06-30
$75.43M
2026-03-31
$32.48M
2025-12-31
$22.48M
2025-09-30
$50.86M
淨利潤率
2026-06-30
28.86%
2026-03-31
15.08%
2025-12-31
9.22%
2025-09-30
21.24%
每股收益
2026-06-30
$1.28
2026-03-31
$0.79
2025-12-31
$0.57
2025-09-30
$1.08
息稅折舊攤銷前利潤
2026-06-30
$102.3M
2026-03-31
$48.88M
2025-12-31
$51.73M
2025-09-30
$73.45M
有效稅率
2026-06-30
19.12%
2026-03-31
18.13%
2025-12-31
44.83%
2025-09-30
24.63%
| 項目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 營業收入 | $261.28M | $215.38M | $243.77M | $239.45M |
| 營業支出 | $108.76M | $133.58M | $136.67M | $114.31M |
| 淨利潤 | $75.43M | $32.48M | $22.48M | $50.86M |
| 淨利潤率 | 28.86% | 15.08% | 9.22% | 21.24% |
| 每股收益 | $1.28 | $0.79 | $0.57 | $1.08 |
| 息稅折舊攤銷前利潤 | $102.3M | $48.88M | $51.73M | $73.45M |
| 有效稅率 | 19.12% | 18.13% | 44.83% | 24.63% |
常見問題
風險提示
股價可能大幅波動，短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考，不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。